Pathstone Holdings’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.57M Buy
69,638
+2,553
+4% +$57.3K ﹤0.01% 1256
2026
Q1
$1.51M Sell
67,085
-923
-1% -$21.2K 0.01% 1188
2025
Q4
$1.62M Buy
68,008
+307
+0.5% +$7.64K 0.01% 1146
2025
Q3
$1.78M Buy
67,701
+1,497
+2% +$38.5K 0.01% 1100
2025
Q2
$1.89M Sell
66,204
-404
-0.6% -$10.8K 0.01% 1031
2025
Q1
$1.66M Buy
66,608
+7,024
+12% +$167K 0.01% 1088
2024
Q4
$1.35M Buy
59,584
+23,489
+65% +$510K 0.01% 1194
2024
Q3
$769K Buy
36,095
+2,817
+8% +$55.4K ﹤0.01% 1508
2024
Q2
$635K Buy
33,278
+2,502
+8% +$51K ﹤0.01% 1565
2024
Q1
$593K Buy
30,776
+16,340
+113% +$324K ﹤0.01% 1597
2023
Q4
$301K Buy
+14,436
New +$277K ﹤0.01% 1826

Other funds holding FMS

Pathstone Holdings's FMS Position: Q2 2026 in Review

Pathstone Holdings increased its Fresenius Medical Care (FMS) stake by 3.8% in Q2 2026, buying an estimated $57.3K and bringing the position to 69,638 shares worth $1.57M. The position accounts for ﹤0.01% of the portfolio, ranked #1256.

Pathstone Holdings first reported a position in FMS in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.89M in Q2 2025. 234 funds tracked by Wall St. Rank hold FMS as of Q2 2026.

  • Pathstone Holdings held 69,638 shares of Fresenius Medical Care worth $1.57M as of Q2 2026.
  • Pathstone Holdings bought 2,553 Fresenius Medical Care shares in Q2 2026, an estimated $57.3K.
  • Fresenius Medical Care made up ﹤0.01% of Pathstone Holdings's portfolio in Q2 2026, its #1256 holding.
  • Pathstone Holdings first reported a position in Fresenius Medical Care in Q4 2023 and has held it in 11 quarters since.
  • Pathstone Holdings's Fresenius Medical Care position peaked at $1.89M in Q2 2025.
  • 234 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.